BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 11568577)

  • 21. Medialization thyroplasty with a customized silicone implant: clinical experience.
    Chrobok V; Pellant A; Sram F; Fric M; Praisler J; Prymula R; Svec JG
    Folia Phoniatr Logop; 2008; 60(2):91-6. PubMed ID: 18235197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined arytenoid adduction and laryngeal reinnervation in the treatment of vocal fold paralysis.
    Chhetri DK; Gerratt BR; Kreiman J; Berke GS
    Laryngoscope; 1999 Dec; 109(12):1928-36. PubMed ID: 10591349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal voice quality changes following Isshiki thyroplasty type I: the Yale experience.
    Sasaki CT; Leder SB; Petcu L; Friedman CD
    Laryngoscope; 1990 Aug; 100(8):849-52. PubMed ID: 2166192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impacts and limitations of medialization thyroplasty on swallowing function of patients with unilateral vocal fold paralysis.
    Tateya I; Hirano S; Kishimoto Y; Suehiro A; Kojima T; Ohno S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):84-7. PubMed ID: 20879825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Montgomery thyroplasty implant system.
    Montgomery WW; Montgomery SK
    Ann Otol Rhinol Laryngol Suppl; 1997 Sep; 170():1-16. PubMed ID: 9302919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Montgomery thyroplasty implant under local anesthesia for unilateral laryngeal paralysis].
    Michel F; Hans S; Crevier-Buchman L; Brasnu D; Menard M; Laccourreye O
    Ann Otolaryngol Chir Cervicofac; 2003 Nov; 120(5):259-67. PubMed ID: 14726844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arytenoid adduction and type I thyroplasty in the treatment of aphonia.
    Slavit DH; Maragos NE
    J Voice; 1994 Mar; 8(1):84-91. PubMed ID: 8167793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [External vocal fold medialization: surgical experiences and modifications].
    Friedrich G
    Laryngorhinootologie; 1998 Jan; 77(1):7-17. PubMed ID: 9522307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medialization thyroplasty in glottis insufficiency due to unilateral vocal fold paralysis and after laser cordectomies - preliminary report.
    Rzepakowska A; Osuch-Wójcikiewicz E; Sielska-Badurek E; Niemczyk K
    Otolaryngol Pol; 2017 Feb; 71(1):22-29. PubMed ID: 28485294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minifenestration type I thyroplasty using an expanded polytetrafluoroethylene implant.
    Stasney CR; Beaver ME; Rodriguez M
    J Voice; 2001 Mar; 15(1):151-7. PubMed ID: 12269631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyapatite versus titanium implant: Comparison of the functional outcome after vocal fold medialization in unilateral recurrent nerve paralysis.
    Storck C; Fischer C; Cecon M; Schmid S; Gambazzi F; Wolfensberger M; Brockmann M
    Head Neck; 2010 Dec; 32(12):1605-12. PubMed ID: 20310039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of thyroplasty for vocal fold paralysis].
    Grøntved AM; Faber CE; Jakobsen J
    Ugeskr Laeger; 2009 Jan; 171(3):117-21. PubMed ID: 19174018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vocal evaluation of thyroplastic surgery in the treatment of unilateral vocal fold paralysis.
    Gray SD; Barkmeier J; Jones D; Titze I; Druker D
    Laryngoscope; 1992 Apr; 102(4):415-21. PubMed ID: 1556891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of thyroplasty in the management of sulcus vocalis.
    Kandoğan T
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):13-7. PubMed ID: 17483605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of different treatment modalities for glottic insufficiency.
    Dursun G; Boynukalin S; Ozgursoy OB; Coruh I
    Am J Otolaryngol; 2008; 29(1):7-12. PubMed ID: 18061825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glottic closure patterns: type I thyroplasty versus type I thyroplasty with arytenoid adduction.
    Li AJ; Johns MM; Jackson-Menaldi C; Dailey S; Heman-Ackah Y; Merati A; Rubin AD
    J Voice; 2011 May; 25(3):259-64. PubMed ID: 20335002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arytenoid adduction with medialization laryngoplasty versus injection or medialization laryngoplasty: the role of the arytenoidopexy.
    Mortensen M; Carroll L; Woo P
    Laryngoscope; 2009 Apr; 119(4):827-31. PubMed ID: 19263407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medialization thyroplasty for cancer-related unilateral vocal fold paralysis.
    Lam PK; Ho WK; Ng ML; Wei WI
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):440-4. PubMed ID: 17321874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vocal fold medialization in children: injection laryngoplasty, thyroplasty, or nerve reinnervation?
    Sipp JA; Kerschner JE; Braune N; Hartnick CJ
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):767-71. PubMed ID: 17709613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biomechanics of the medialization laryngoplasty (thyroplasty type 1) in an ex vivo canine model.
    Noordzij JP; Opperman DA; Perrault DF; Woo P
    J Voice; 1998 Sep; 12(3):372-82. PubMed ID: 9763188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.